The number of pharmaceutical company-sponsored physician meetings and events skyrocketed from 70,000 in 1993 to 280,000 in 1999, according to Newtown, PA-based Scott-Levin's Physician Meeting & Event Audit. Between 1998 and 1999, the number of events held for doctors jumped 25%.
The number of pharmaceutical company-sponsored physician meetings and events skyrocketed from 70,000 in 1993 to 280,000 in 1999, according to Newtown, PA-based Scott-Levin's Physician Meeting & Event Audit. Between 1998 and 1999, the number of events held for doctors jumped 25%.
Meetings and events continue to be an effective way to get doctors' attention, according to PMEA's annual invitation analysis. Physicians attended almost half (47%) of the events they were invited to in 1999.
Doctors were more likely to accept invitations to events associated with a pharmaceutical company. While physicians said yes to only 40% of invitations not associated with a manufacturer last year, they accepted 49% of invitations associated with a drug firm.
Who actually makes the invitation matters, too. Pharmaceutical sales representatives extended 65% of all invitations; however, physicians accepted only about half (47%) of those invitations. Doctors were more likely to say yes (59%) when a third-party organization made the invitation on behalf of the manufacturer.
To attract physicians to meetings, companies are getting more creative. Invitations collected in 1999 included celebrity autograph signings, wine tastings, mystery dinner theaters, shows and family outings such as Halloween hayrides and trips to the zoo.
However, doctors reported that many (45%) 1999 invitations were for events at restaurants, with a 38% acceptance rate. Hotel locations accounted for 18% of invitations, with 45% being accepted.
Only 4% of events were held in physicians' homes, but these had the highest acceptance rate: 87%. Offices and research facilities were used as locations even less often, but when they were, acceptance rates hovered around 70% to 80%.
Physicians told Scott-Levin that a meeting's subject matters most. In 1999, 74% of doctors cited "interest in the topic" as a main reason for attending events. A convenient location was cited by half, and honoraria, reputation of the speaker and continuing medical education credits were also mentioned as important.
Scott-Levin's audit reported that the main reason for declining a meeting invitation was a scheduling conflict , according to 68% of physicians, followed by an inconvenient location (18%) and lack of interest in a topic (17%).
Allergists-immunologists had the highest acceptance rate for event invitations (68%). Acceptance was also highest among doctors in practice for 26 years or more (54%). PR
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Beyond the Prescription: The Role Pharma Plays in Digital Health Conversations
April 1st 2025As social media continues to influence healthcare communication, it presents both challenges and opportunities for the pharmaceutical industry. In this interview, Jennifer Harakal of Canopy Life Sciences discusses balancing compliance with effective digital engagement to build trust and facilitate meaningful healthcare conversations.